Prescription for 2022 - These Health Care Stocks Should Thrive
Kiplinger's Personal Finance|January 2022
Pharmaceutical and health sciences firms are riding powerful demographic trends amid a golden age of innovation.
By Andrew Tanzer. Photographs by Novo Nordisk

AS THE COVID-19 PANDEMIC recedes, routine doctor and hospital visits, along with deferred medical procedures such as cataract surgery and heart valve replacements, are returning to normal. The pandemic has been a global tragedy, but if there is one silver lining it is that the miraculous development of effective COVID-19 vaccines in less than a year is helping to usher in a golden age for the pharmaceutical and health sciences industries.

“We’re seeing a revolution today in vaccine development,” says Andy Acker, manager of Janus Henderson Global Life Sciences. Before COVID arrived, the fastest vaccine approval had been four years, and the average was 10 years; with COVID, two vaccines were approved in about 10 months. Validation of the mRNA technology used by Pfizer and Moderna in their vaccines means that it will now be adopted to treat other medical indications. (The mRNA vaccines teach our cells how to make a protein that triggers an immune response.)

In truth, the COVID-19 medical challenge and the dramatic success of the vaccines have only served to accelerate a powerful trend of innovation in medicine. For instance, the sharply declining cost of gene sequencing is pushing forward the growing field of precision medicine, which aims to tailor treatments to specific diseases, such as cancer. “The science is exponentially improving for better outcomes,” says Neal Kaufman, manager of Baron Health Care fund.

Of course, the health care sector is also riding the (global) demographic wave of aging populations. At CVS Health drugstores, the number of prescription medicines purchased by people age 65 or older is three to four times that of 20- to 40-year-old people, says Jason Kritzer, comanager of Eaton Vance Worldwide Health Sciences. In rapidly developing countries with expanding middle classes, such as China, quality health care is likely to be one of the first things people rising out of poverty will spend money on.

With innovation and some of these secular trends in mind, we identified six intriguing health care stocks that literally span the alphabet, from letter A to letter Z. We particularly like companies that address large and growing end markets, especially global ones. We give extra points to businesses that have less exposure to pricing pressure from insurance companies or the government. Returns and other data are through November 5.

ALIGN TECHNOLOGY. Maker of the Invisalign brand of clear, plastic braces for teeth, Align Technology is a disruptive force in the global teeth-correction market, rapidly gobbling market share from traditional wires and brackets. Jeff Mueller, comanager of Polen Global Growth, credits the “Zoom effect” for accelerating the adoption of the aesthetically pleasing aligners: Workers stuck at home during the pandemic were staring at their own teeth every day on Zoom. “Vanity is increasing around the world,” Mueller says, adding that, due to the rise of smartphones, the internet and social media, “more people are taking pictures of themselves than ever before in the history of mankind.”

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM KIPLINGER'S PERSONAL FINANCEView All

WHY EVERYONE IS TALKING ABOUT NFTs

Non-fungible tokens are unique digital properties that use blockchain technology. Our FAQ will help you understand what all the buzz is about.

7 mins read
Kiplinger's Personal Finance
May 2022

Subdued Stock Returns Ahead

This well-known strategist says dividends are a bright spot in an otherwise muted market.

5 mins read
Kiplinger's Personal Finance
May 2022

Why Bonds Belong in Your Portfolio

STREET SMART

5 mins read
Kiplinger's Personal Finance
May 2022

WHEN CAN YOU GET A DEAL ON A CAR AGAIN?

Low inventories mean it’s hard to haggle on price, but you can still negotiate on financing.

3 mins read
Kiplinger's Personal Finance
May 2022

Weathering the Market's Turns

Our favorite actively managed funds delivered mixed results, proving that portfolio diversification matters over the course of a market cycle.

10+ mins read
Kiplinger's Personal Finance
May 2022

The Lowdown on Living Trusts

A trust can solve a lot of problems. But like all tools, it can also be misused.

10+ mins read
Kiplinger's Personal Finance
May 2022

Our Picks Struggle Along With the Market

THE KIPLINGER ESG 20 UPDATE | After a bullish 2021 for stocks with impressive ESG credentials, a pullback is under way.

2 mins read
Kiplinger's Personal Finance
May 2022

How to Open a Brokerage Account

Investing can be fun, but you need a brokerage account to do it. Fortunately, it’s easy to get started.

5 mins read
Kiplinger's Personal Finance
May 2022

Talking Money With Your Spouse

MONEY SMART WOMEN

3 mins read
Kiplinger's Personal Finance
May 2022

Start the Elder Care Conversation

LIVING IN RETIREMENT | The communication gap between parents and their adult kids is stunning.

3 mins read
Kiplinger's Personal Finance
May 2022
RELATED STORIES

Invest and Rest

Now almost anyone can invest in a hedge fund

4 mins read
Men's Fitness South Africa
March - April 2022

‘HODL': A Typo Takes Hold as a Sound Cryptocurrency Strategy

Late in 2013, with bitcoin prices in the middle of a steep dip, a post appeared in an online forum featuring a misspelling that would become legendary: “I AM HODLING.”

4 mins read
AppleMagazine
March 11, 2022

Need a Hug?

Speculative assets lead a market selloff, but corporate cash could put a floor under prices

9 mins read
Bloomberg Businessweek
January 31, 2022

'The World Is On the Brink'

Less than a year before president john F. Kennedy delivered his Commencement Address at the American University in 1963, the Cuban Missile Crisis had brought the world to the brink of nuclear war.

9 mins read
Newsweek
January 21, 2022

Last Sane Man on Wall Street

Nathan Anderson made his name exposing—and betting against—corporate fraud. But short selling in a frothy pandemic economy can be ruinous.

10+ mins read
New York magazine
January 17 - 30, 2022

When to Launch Something Illegal

Some business ideas are good enough to change the law. But you may never know unless you build it first.

3 mins read
Entrepreneur
January - February 2022

Yes, You Can Grow Too Fast

As a venture capitalist, I’ve seen how “blitzscaling” damages companies, people, and the planet. Now my money is on “responsible growth.”

5 mins read
Entrepreneur
January - February 2022

The Money Game: Anonymous

A Trip to the Meme-Coin Casino “I think this is all stupid and absurd. But I’m not going to complain.”

7 mins read
New York magazine
January 3-16, 2022

3 Times You Need Money Advice from a Human

You can now manage most aspects of your money without ever consulting another human being. You can budget, borrow, save, invest, buy insurance, prepare your tax return and create a will — among many other tasks — by using apps, websites and software.

4 mins read
AppleMagazine
November 26, 2021

Responsible-Investing Pioneer Lydenberg Says ESG Needs An Upgrade

STEVE LYDENBERG’S passion for social change was inspired by anti-Vietnam War demonstrations, consumer boycotts, and the movement to divest from apartheid South Africa. But he didn’t take to the streets. Instead, Lydenberg turned to the world of finance to help catalyze societal change.

8 mins read
Bloomberg Markets
October - November 2021